MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Acute Myeloid Leukemia Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,888 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,888 works in the cohort · of 4,299,418page 2 of 58

Labels cover 3 of 2,888 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,888 of 2,888 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Age-related clonal hematopoiesis
Liran I. Shlush
2017· review· en· Blood· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
283
citations
fundno affunlabeled
RUNX transcription factors: orchestrators of development
Renaud Mével, Julia Draper, Michael Lie‐A‐Ling, Valérie Kouskoff, Georges Lacaud
2019· review· en· Development· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
230
citations
afffundno abstractunlabeled
Concepts of human leukemic development
Jennifer K Warner, Jean Wang, Kristin J. Hope, Liqing Jin, John E. Dick
2004· review· en· Oncogene· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
225
citations
afffundunlabeled
Acute Myeloid Leukemia Stem Cells
John E. Dick
2005· review· en· Annals of the New York Academy of Sciences· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
194
citations
affunlabeled
Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia.
Stephen H. Petersdorf, Kenneth J. Kopecky, Robert K. Stuart, Richard A. Larson, Thomas J. Nevill, Leif Stenke +5 more
2009· article· en· Blood· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
183
citations
← previousnext →

How this was built: Screen · Findings · About